Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Starpharma.
RELATED STOCKHEAD STORIES
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: Gains in Gold and Tech stocks offset by losses in Energy as oil price retreats
Health & Biotech
ASX Health Stocks: Starpharma suffers setback as FDA rejects appeal, shares down 10pc
Health & Biotech
ASX Health Stocks: Starpharma says Viraleze reduces viral load in nose, effective in Covid-19
Health & Biotech
ASX Health Stocks: dorsaVi up 27pc on US deals, Starpharma reports positive outcome on Phase 2 trial
Health & Biotech
“Market is going to be surprised” as Firebrick Pharma set to launch antiviral nasal spray, Nasodine
Health & Biotech
ASX Health Stocks: Noxopharm jumps +50pc on mRNA vaccine results; Starpharma +25pc on Phase 2 study
Health & Biotech
ASX Health Stocks: Starpharma full steam ahead on VIRALEZE study, Dimerix to use QYTOVRA as brand name
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: Tempus Trap, ASX200 loses its bottle, James Bay makes more hay on 2nd day
News
In Case You Missed It: A consumer products divestment and a dash of lithium
News
ASX Small Caps Lunch Wrap: Who else is up to something totally pointless today?
Health & Biotech
ASX Health Stocks: Starpharma jumps 30pc after cancer drug helps enable ‘100 per cent’ control rate
News
Top 10 at 11: Starpharma has excellent drug trial news, Firebrick doesn’t and NIS takes a breather
News
Market Highlights: ASX to fall as Big Tech retreats; and here’s how Aussies are being duped by scammers
Health & Biotech
ASX Health Stocks: Starpharma jumps 10pc on study results; Mach7 announces $3.7m deal
Health & Biotech